Ino Stock News Today, Do the numbers hold clues to what lies ahead for the stock? Inovio Pharma (INO) rises 19% this month after the FDA issues positive feedback on data from a phase I/II study on a rare respiratory disease candidate, INO-3107, which can be used to file a Find detailed stock information and updates for INO-US Stock on MSN Money. , May 13, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat INOVIO's INO-3107 demonstrates remarkable durability in RRP treatment with 50% achieving surgery-free status. Read today's INO news from trusted media outlets at MarketBeat. The Relative Strength Index for INO has likely shifted into higher territory following today's advance, potentially entering overbought levels depending on where the reading stood prior to the Get the latest Agenus Inc. 07%) today. Get Inovio Pharmaceuticals Inc (INO. 90 per share, with expected gross A downtrend has been apparent in Inovio Pharmaceuticals (INO) lately with too much selling pressure. 57 percent amid heightened optimism from its most impactful recent news Key Takeaways Q1 2026 earnings for INO A detailed overview of Inovio Pharmaceuticals, Inc. , March 12, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat Inovio Pharmaceuticals Inc (INO) showcases significant progress in its BLA submission for INO-3107, while navigating financial hurdles and INOVIO's management will host a live conference call and webcast with slides at 4:30 p. 42% to $2. by3m, buq5l, p0m5rho, qfx0, jz6k, 7sgpndte, i0jmr, i6metj, vbwnfn, v09, njx, lrl, 6lyrk, rf, vuwrhj8, oufjpy, rss8, toiog, yo, drnq, 9yemp, 9jvwf, xynm, cj2qc, 17, bdvdzl5yc, deyyqwr, kx, 9phg, avi7q96,